It has been revealed by The Independent that British drug company GlaxoSmithKline is being investigated following claims its employees bribed doctors in China to supply their pharmaceutical products. It has been alleged that the scandal, involving four employees including a vice president, went undetected by the internal bribery and corruption policy, through the use of travel agencies and consultancy firms.
The president of its Asia-Pacific branch has been forced to admit that executives “appear” to have broken the law. The financial director has not been arrested but it is thought he has been banned from leaving the country.
Corruption is unfortunately often synonymous with Thailand but the government are trying their hardest to tackle the well known problem. There are in fact many laws in Thailand designed to prevent corruption including many Thailand criminal laws. In addition there are also regulations that indirectly manage corrupt practices. Americans conducting business in Thailand also need to remain aware that there is then also the possibility of international prosecution under the Thai Foreign Corrupt Practices Act. The FCPA contains two sections: one related to accounting and the other related to anti-bribery.
Read the full story here
Comments on this entry are closed.